Johnson & Johnson’s Janssen COVID-19 vaccine overview and safety

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Johnson & Johnson’s Janssen COVID-19 vaccine overview and safety

Feb. 22, 2022
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

[PDF-361.17 KB]

English

Details Supporting Files You May Also Like

Details:

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

Updated Feb. 22, 2022

People who received one dose of J&J/Janssen who want an additional dose or a booster are encouraged to get a Pfizer-BioNTech vaccine.
Subjects:

[+]

Child Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19/prevention & Control Viral Vaccines
Document Type:

Webpage
Name as Subject:

Johnson & Johnson’s Janssen COVID-19 vaccine
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:642fdbecc748a51aa35f7e516e30ec7fde5aa3b1e2ab132bd66b55d5f9c9fb7b
Download URL:

https://stacks.cdc.gov/view/cdc/114717/cdc_114717_DS1.pdf
File Type:

Pfizer-BioNTech.html

htm

More +